Cancer Data Trends 2024: B-Cell Lymphoma

Telehealth can be a valuable option for veterans living in rural areas with limited access to in-person VA care.⁹

While data on the efficacy of telehealth are mostly limited to surveillance and oral therapy, a recent small study of veterans with aggressive lymphoma showed no significant differences in care between patients receiving infusional chemoimmunotherapy administered by an in-person VA oncologist or under the direction of a remote teleoncologist through the VA's National TeleOncology program (NTO).¹⁰

^{CRR, complete response rate; ORR, overall response rate; OS, overall survival; R-CHP, rituximab, cyclophosphamide, doxorubicin, and prednisone; R-CHOP-X, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone combined with targeted agents}

^{BTKi, Bruton tyrosine kinase inhibitor; r/r, relapsed/refractory}

^{CAR-T, chimeric antigen receptor T-cell}

^{BiTE, bispecific T-cell engager}